American Society of Hematology

American Society of Hematology The world's largest professional society concerned with the causes and treatments of blood disorders.

Immune-mediated thrombocytopenic purpura (iTTP) has undergone one of the most remarkable transformations in modern hemat...
08/23/2026

Immune-mediated thrombocytopenic purpura (iTTP) has undergone one of the most remarkable transformations in modern hematology.

Once considered almost universally fatal, it is now a largely treatable disease due to advances in therapeutic plasma exchange (TPE), immunosuppression, and targeted therapy.

Nevertheless, important challenges remain in early diagnosis, equitable access to treatment, relapse prevention, and long-term patient outcomes.

Read more about our evolving understanding of iTTP in the July/August issue of The Hematologist: https://ow.ly/I38350ZCHRC

Get more from your hematology review. 📖 Pair the ASH Hematology Review Series with ASH-SAP for a comprehensive learning ...
08/22/2026

Get more from your hematology review. 📖

Pair the ASH Hematology Review Series with ASH-SAP for a comprehensive learning experience. The HRS + ASH-SAP bundle offers:

🩸 Expert-led review lectures

🩸 Interactive study sessions

🩸 Access to ASH SAP 9 study guide & ASH Q&A Bank app, with more than 300 practice questions & multiple practice exams

Ideal for fellows preparing for boards and hematologists looking for a comprehensive refresher.

Explore HRS and the HRS + ASH-SAP bundle today: https://ow.ly/Spw350ZCI4x

Blood Journals Portfolio

When funding for research on health disparities in hematology is under pressure, ASH is stepping up. Research improving ...
08/21/2026

When funding for research on health disparities in hematology is under pressure, ASH is stepping up. Research improving health outcomes across communities cannot wait.

Applications are now open for the ASH Treating Fairly Research Award, supporting research that uncovers the causes of disparities in hematology care and develops interventions to improve outcomes.

Advance your work. Expand your impact. Apply today.

https://ow.ly/aFKr50ZCpnj

Calling hematology trainees! Get ready to learn, connect, and explore at ASH-a-Palooza, the premier trainee event at the...
08/21/2026

Calling hematology trainees! Get ready to learn, connect, and explore at ASH-a-Palooza, the premier trainee event at the 68th ASH Annual Meeting and Exposition.

If you're planning to attend , be sure to join us on Friday, December 11, from 12:00 p.m. – 5:00 p.m. in New Orleans.

Here's what to expect:

🤝 Blood Buddies: Speed mentoring rotations with hematology leaders.

🎤 ASH Talks: TED-style presentations featuring dynamic speakers and timely topics.

💡 Blood Drops: Bite-sized career development presentations with practical tips for success across a variety of career tracks.

🩸 Blood Booths: Interactive booths highlighting ASH programs, career resources, and opportunities in hematology.

Learn more: https://ow.ly/5pHE50ZC4yG

Share your expertise with the world! Apply for the Health Volunteers Overseas (HVO) hematology program for the opport...
08/20/2026

Share your expertise with the world!

Apply for the Health Volunteers Overseas (HVO) hematology program for the opportunity to take part in:

🩸 Clinical rounds and bedside consultations

🩸 Classrooms lectures for on-site and trainees

🩸 Laboratory training

🩸 And so much more, at hospitals in Cambodia, Peru, and Tanzania

Apply today and make a difference: https://ow.ly/18jH50ZC2yT

08/20/2026

B-ALL treatment decisions can look very different from initial diagnosis through relapsed or refractory disease.

In the latest HemeTalks, Adam Duvall, a specialist in pediatric blood cancers, shares practical, up-to-date guidance for managing B-ALL across the treatment journey, including:

👉Newly ddiagnosed: Which patients qualify for asparaginase containing pediatric inspired induction regimens

👉Relapsed/refractory: The roles of blinatumomab and inotuzumab ozogamicin as off-the-shelf therapies

👉CAR-T therapy: Comparison of the three approved products and the growing evidence supporting CAR-T as a destination therapy for a meaningful subset of patients

🎧 Listen now: https://ow.ly/arBE50ZBEma

ASH Education

Every future hematologist starts somewhere. Know a medical student who would enjoy hematology? Tag a medical student or ...
08/19/2026

Every future hematologist starts somewhere.

Know a medical student who would enjoy hematology? Tag a medical student or share this post with them to introduce them to Horizons in Hematology on ASH Connections. Here, they’ll find videos, interactive activities, games, resources, and a community of peers, all in one place.

Learn more: https://ow.ly/I29e50ZBqLp

The FDA’s recent approval of an all-oral regimen for newly diagnosed AML is poised to have substantial impact on individ...
08/18/2026

The FDA’s recent approval of an all-oral regimen for newly diagnosed AML is poised to have substantial impact on individual patients, as well as the operational workflows and care models at cancer centers.

Learn more about the potential pros and cons of emerging stratgies in the July/August issue of The Hematologist: https://ow.ly/xeKv50ZATtC

ASH invests in the next generation of hematologists and researchers. Applications are now open for several ASH Awards of...
08/18/2026

ASH invests in the next generation of hematologists and researchers. Applications are now open for several ASH Awards offering research funding, mentorship, protected research time, and career development support.

ASH’s universal award application is a streamlined process that lets eligible medical students, residents, and graduate students submit one application and be considered for multiple ASH award programs at their career level. Explore available awards and find the opportunity that fits your career stage: https://ow.ly/yV9050ZAUwV

Know someone who may be eligible? Share these opportunities with them.

Functional hematopoietic stem cells with unique gene signatures reside in the adult human lung and can be mobilized for ...
08/17/2026

Functional hematopoietic stem cells with unique gene signatures reside in the adult human lung and can be mobilized for stem cell transplantation.

Join the next ASH Journal Club webinar on August 28 to:

Understand the transcriptional and functional biases of lung vs. bone marrow hematopoietic progenitor cells.

Learn about the anatomic location and niche of lung hematopoietic progenitor cells.

Explore the potential role of extramedullary hematopoietic progenitor cells in stem cell transplantation therapy.

Enroll today: https://ow.ly/mBMS50ZA2bI

Blood Journals Portfolio

Address

2021 L Street NW, Suite 900
Washington D.C., DC
20036

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+12027760544

Website

Alerts

Be the first to know and let us send you an email when American Society of Hematology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share